Abstract
Nanofibers became one of the major research areas for drug delivery and tissue engineering applications in the last decade. Depending on the simplicity of the preparation method and high drug loading capacity, nanofibers provide many advantages for therapeutic perspectives. In addition, combined systems such as embedding nanoparticles into the nanofiber structures provide a second option for delivery of dual active ingredients in the same formulation. The release rate of the active ingredients can also be modified easily by the formulation parameters depending on the desired release time for treatment. Nanofibers systems are used for the delivery of antibiotics, anticancer drugs, analgesics, hemostatic agents and various proteins for tissue engineering purposes. In addition, various applications such as medical device coating also provide new insights for the clinical use of nanofibers. The most commonly used technique for preparation of nanofibers is the electrospinning, which provides feasibility background for scale up process from laboratory to the industrial applications. The main boundary for nanofibers is the limitations for systemic route. Nanofibers are mainly designed for the delivery of active ingredients for local purposes. Regardless of the therapeutic aim, nanofibers are also perfect 3 dimensional structures that are suitable for tissue regeneration. They provide matrix structure for cell regeneration especially in applications for wound healing. This review is mainly focused on the recent advances on the preparation of nanofibers, applications for drug delivery, tissue engineering and wound healing purposes.
Keywords: Nanofiber, Drug Delivery, Pharmaceutical Applications, Tissue Engineering, Drug release kinetics, Chemotherapeutic agents.
Current Topics in Medicinal Chemistry
Title:Nanofibers: New Insights for Drug Delivery and Tissue Engineering
Volume: 17 Issue: 13
Author(s): Mohammad Karim Haidar and Hakan Eroglu*
Affiliation:
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, P.O. Box: 06100, Ankara,Turkey
Keywords: Nanofiber, Drug Delivery, Pharmaceutical Applications, Tissue Engineering, Drug release kinetics, Chemotherapeutic agents.
Abstract: Nanofibers became one of the major research areas for drug delivery and tissue engineering applications in the last decade. Depending on the simplicity of the preparation method and high drug loading capacity, nanofibers provide many advantages for therapeutic perspectives. In addition, combined systems such as embedding nanoparticles into the nanofiber structures provide a second option for delivery of dual active ingredients in the same formulation. The release rate of the active ingredients can also be modified easily by the formulation parameters depending on the desired release time for treatment. Nanofibers systems are used for the delivery of antibiotics, anticancer drugs, analgesics, hemostatic agents and various proteins for tissue engineering purposes. In addition, various applications such as medical device coating also provide new insights for the clinical use of nanofibers. The most commonly used technique for preparation of nanofibers is the electrospinning, which provides feasibility background for scale up process from laboratory to the industrial applications. The main boundary for nanofibers is the limitations for systemic route. Nanofibers are mainly designed for the delivery of active ingredients for local purposes. Regardless of the therapeutic aim, nanofibers are also perfect 3 dimensional structures that are suitable for tissue regeneration. They provide matrix structure for cell regeneration especially in applications for wound healing. This review is mainly focused on the recent advances on the preparation of nanofibers, applications for drug delivery, tissue engineering and wound healing purposes.
Export Options
About this article
Cite this article as:
Haidar Karim Mohammad and Eroglu Hakan*, Nanofibers: New Insights for Drug Delivery and Tissue Engineering, Current Topics in Medicinal Chemistry 2017; 17 (13) . https://dx.doi.org/10.2174/1568026616666161222102641
| DOI https://dx.doi.org/10.2174/1568026616666161222102641 |
Print ISSN 1568-0266 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Artificial intelligence and In Silico Strategies for Novel Target Identification in Alzheimer's Disease
The title "Artificial Intelligence and In Silico Strategies for Novel Target Identification in Alzheimer's Disease" emphasizes the use of Artificial intelligence (AI) and advanced in silico methods to address Alzheimer's disease (AD), a neurodegenerative condition that currently has few effective treatments. AI and insilico methods, including molecular modeling, simulations, are ...read more
Big Data in Biomedicine: Integrating Bioinformatics and Clinical Databases
The rapid advancement of big data technologies is transforming biomedicine by integrating bioinformatics and clinical databases to drive precision medicine and innovative healthcare solutions. This thematic issue explores the intersection of computational biology, machine learning, and biomedical informatics, highlighting how large-scale data analysis enhances disease diagnosis, biomarker discovery, and personalized ...read more
Enzyme-Targeted Drug Discovery: Emerging Targets, Strategic Approaches, and Evaluation Frameworks
Enzyme-targeted drug discovery represents one of the most relevant strategies in pharmaceutical development, owing to the high specificity, selectivity, and central role of enzymes in the regulation of biological processes. This proposed issue aims to compile key information on the current landscape of enzyme-targeted drug discovery, with emphasis on the ...read more
From Code to Cure: The Evolving Landscape of Computer-Aided Drug Discovery and AI-Driven Design
Advancements in computational science and high-performance computing have made computer-aided drug design (CADD) a fundamental approach in modern drug discovery. CADD enables precise molecular-level analysis of target binding sites and interaction mechanisms, expediting the identification and refinement of drug candidates. It comprises structure-based drug design (SBDD), enhanced by crystallography and ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Predicting Glioma Cell Differentiation-inducing Drugs Using a Drug
Repositioning Strategy
Combinatorial Chemistry & High Throughput Screening Recent Patents, Formulation and Characterization of Nanoliposomes
Recent Patents on Drug Delivery & Formulation CPP-Based Bioactive Drug Delivery to Penetrate the Blood-Brain Barrier: A Potential Therapy for Glioblastoma Multiforme
Current Drug Targets Bypassing Cancer Resistance by Antagonizing “Inhibitor of Apoptosis Proteins” (IAPs)
Current Signal Transduction Therapy How is Gene Transfection Able to Improve Current Chemotherapy? The Role of Combined Therapy in Cancer Treatment
Current Medicinal Chemistry Protein Tyrosine Phosphatases: Strategies for Distinguishing Proteins in a Family Containing Multiple Drug Targets and Anti-Targets
Current Pharmaceutical Design Antibacterial Assessment of Zinc Sulfide Nanoparticles against <i>Streptococcus pyogenes</i> and <i>Acinetobacter baumannii</i>
Current Topics in Medicinal Chemistry Recent Progress on the Role of Fibronectin in Tumor Stromal Immunity and Immunotherapy
Current Topics in Medicinal Chemistry New Approaches in Glioblastoma Multiforme: The Potential Role of Immune- check Point Inhibitors
Current Cancer Drug Targets Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway
Recent Patents on Anti-Cancer Drug Discovery MTA1: A Vital Modulator in Prostate Cancer
Current Protein & Peptide Science Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology Drug Delivery Across the Blood-Brain Barrier
Current Nanoscience The Cross-talk between Tristetraprolin and Cytokines in Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeting the Brain: Advances in Drug Delivery
Current Pharmaceutical Biotechnology Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry A Review of Studies on Targeting Interleukin 4 Receptor for Central Nervous System Malignancy
Current Molecular Medicine Alkaloids from Cyanobacteria with Diverse Powerful Bioactivities
Mini-Reviews in Medicinal Chemistry Nanoparticles as Novel Carrier for Brain Delivery: A Review
Current Pharmaceutical Design Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription Factor
Current Pharmaceutical Design





